ArticleScientific reports2025
Association between healthy beverage index and odds of diminished ovarian reserve in a case-control study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of diet in the pathogenesis and management of premature ovarian insufficiency.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diminished ovarian reserve, linked to reduced fertility and adverse reproductive outcomes, can be influenced by a number of modifiable factors while it's not clearly known that whether the quality of beverage intake can affect ovarian reserve. So, we aimed to assess the association of the Healthy Beverage Index (HBI), which offers an innovative approach, with the risk of DOR among a group of women attending a fertility clinic. This case-control study recruited 370 women (120 DOR and 250 with normal ovarian reserve as controls), matched by age and body mass index (BMI). Dietary intakes were assessed using a reliable semi-quantitative food frequency questionnaire (FFQ). The antral follicle count (AFC), and serum anti-Müllerian hormone (AMH) levels were measured as markers of ovarian reserve. The multivariable logistic regression was applied to calculate the association between HBI and risk of DOR. The study findings indicated that in the unadjusted model, there was no significant association between HBI score and the risk of DOR (OR: 0.81; 95% CI: 0.36-1.36). However, after adjusting for confounders such as energy intake, physical activity, and fat mass (FM), women in the highest tertile of HBI score exhibited an 8% reduction in odds of DOR, with an adjusted OR of 0.92 (95% CI: 0.41-0.96). Our findings suggest that greater adherence to the HBI may be modestly associated with reduced odds of DOR. However, given the small effect size and borderline statistical significance, the clinical implications of this association remain uncertain. Further validation through well-designed prospective studies and clinical trials is needed to better understand this potential relationship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.